11-19 更新 实时
首页/ 科技公司/ 正文

「Theranos但真实版」:初创称血检可预测健康风险

科技公司 来源:The Information AI 2026-11-19 00:00 0 阅读 机器翻译

随着 Theranos 事件再度引发广泛关注,两位创业公司创始人 Omar Abudayyeh 和 Jonathan Gootenberg 半开玩笑地决定,花约 12 美元买下网址 theranosbutworks.com 的所有权。

该网址会跳转到他们成立 16 个月的血液与健康检测公司 Helios 的主网站,该公司将于周三走出隐身模式。Abudayyeh(36 岁)和 Gootenberg(35 岁)表示,只需用一个小型无针设备采集一滴血,公司就能检测出人体内 1000 多种蛋白质,从而了解其当前健康状况,并预测一个人未来 10 年罹患心力衰竭、血癌和阿尔茨海默病等疾病的风险。

译文由英文原文机器翻译,术语按行业惯例统一,可在文末展开原文核对。

查看英文原文(‘Theranos But Real’: New Blood-Testing Startup Says It Can Predict Health Risks)

With all the renewed interest around the saga of Theranos, two startup founders, Omar Abudayyeh and Jonathan Gootenberg, made the tongue-in-cheek decision to plunk down about $12 for the rights to the URL: theranosbutworks.com.

That URL redirects to the main website for their 16-month-old health- and blood-testing company, Helios, which is coming out of stealth on Wednesday. With just a drop of blood drawn from a small, needle-free device, Abudayyeh, 36, and Gootenberg, 35, say the company can measure over 1,000 proteins within someone’s body that provide insight into their current state of health and predictions about a person’s risk of diseases like heart failure, blood cancers and Alzheimer’s disease over the next 10 years.

正文保留英文原文,标题与摘要由机器翻译。

本文由采集器自动同步

原文发布于 The Information AI(‘Theranos But Real’: New Blood-Testing Startup Says It Can Predict Health Risks),标题、摘要与正文由机器翻译,术语按行业惯例统一,未经人工逐句校订。

阅读原文 ↗